Rudra Channappanavar
Associate Professor
Veterinary Pathobiology
- Associate ProfessorVeterinary Pathobiology
- 405-744-7224 (Work)
- Oklahoma State University, Veterinary Pathobiology, 250 McElroy Hall, Stillwater, Oklahoma, 74078, United States
FUNDING
- GRANTFEATURED
Featured National Heart Lung and Blood Institute6 Sep 2024 - 30 Jun 2029People funded by this grant:- CHANNAPPANAVAR R
- GRANTFEATURED
Featured Myeloid cell TRAF6 signaling in SARS-CoV-2-induced dysregulated lung immunityNational Institutes of Health1 Jun 2024 - 30 Apr 2026 - GRANTBoehringer Ingelheim Veterinary Scholars Program (VSP) Funding Application 2026Boehringer Ingelheim Vetmedica, Inc.15 May 2026 - 15 Aug 2026
- GRANTEvaluating protective efficacy of inactivated H5N1vaccine with novel STING adjuvants in mouse modelAmerican Veterinary Medical Association1 May 2026 - 31 Aug 2026
- GRANTAcquisition of a confocal microscope for the OCRID Immunopathology CoreOklahoma Center for Adult Stem Cell Research1 Jul 2025 - 31 Dec 2025
- GRANTCytation10 confocal imaging support to immunopathology core and stem cell researchOklahoma Center for Adult Stem Cell Research1 Jul 2025 - 31 Dec 2025
- GRANTBoehringer Ingelheim Veterinary Scholars Program (VSP) Funding Application 2025- Oklahoma State UniversityBoehringer Ingelheim Vetmedica, Inc.12 May 2025 - 15 Aug 2025
- GRANTEvaluation of virus-specific T cell response to FIPV infection in catsMorris Animal Foundation1 May 2025 - 31 Jul 2025
- GRANTEvaluating the protective efficacy of inactivated bovine H5N1 vaccine in an animal modelFoundation for Food and Agricultural Research30 Apr 2025 - 30 Apr 2026
- GRANTUnlocking the zoonotic and reverse-zoonotic potential of coronavirusesFoundation for Food and Agricultural Research6 Sep 2024 - 30 Jun 2025
- GRANTBIVSP Summer Research Training Program (SRTP) 2024Boehringer Ingelheim Vetmedica, Inc.14 May 2024 - 14 Aug 2024
- GRANTTherapeutic evaluation of Extracellular Vesicle-derived Nanoparticle in a mouse model of Long-COVID conditionsOrganicell Regenerative Medicine Inc1 May 2023 - 30 Apr 2024
- GRANTEstablishment of nanoString spatial biology system at OSUOklahoma Center for Adult Stem Cell Research1 Jul 2022 - 30 Jun 2023
- GRANTImmunogenicity and Efficacy of Vaxxinity COVID Vaccines in Transgenic MiceVaxxinity Inc5 Jul 2021 - 28 Feb 2022
- GRANTEvaluation of extracellular vesicle-derived nanoparticle-based therapeutics-EV-for treatment of respiratory disease caused by virus infections of pandemic potentialOrganicell Regenerative Medicine Inc15 Jun 2021 - 14 Jul 2022
- OTHER FUNDINGRole of Interferon lambda in host protection during agingNational Institute of Health/ National Institute on Aging (Primary Institute)15 Aug 2018 - 31 Dec 2020
- GRANTOklahoma Center for Respiratory and Infectious Diseases (Phase II CoBRE)National Institutes of Health16 Jul 2018 - 30 Jun 2024
- GRANTPhase II CoBRE (Oklahoma Center for Respiratory and Infectious Diseases)16 Jul 2018 - 30 Jun 2024